Implantable electrodes containing polyoxometalate anions and methods of manufacture and use

• US 7,991,483 B1
• Filed: 12/21/2006
• Issued: 08/02/2011
• Est. Priority Date: 12/21/2006
• Status: Active Grant

• Current Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Inventors: Schewe, Scott, Weber, Jan, Atanasoska, Liliana, Warner, Robert W.
• Primary Examiner(s): Patel; Niketa I
• Assistant Examiner(s): EL-KAISSI, HIBA CARINE
• Application Number:
  US11/614,870
• Time in Patent Office: 1,685 Days
• Field of Search: 607115-154, 600372-392
• US Class Current: 607/121
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/0553 Paddle shaped electrodes, e.g. for laminotomy
• CPC Class Codes: A61N 1/372 Arrangements in connection with the implantation of stimulators
• CPC Class Codes: A61N 1/37205 Microstimulators, e.g. implantable through a cannula

Abstract

An implantable device includes at least one electrode comprising a conductive base and polyoxometalate anions disposed on or within the conductive base; and at least one conductor attached to the at least one electrode for conducting electrical energy to the at least one electrode.

Claims

1. An implantable microstimulator device, comprising:

a housing;

a power source disposed within the housing;

an electronic subassembly disposed within the housing and coupled to the power source;

at least one electrode disposed on the housing and comprising a conductive base and polyoxometalate anions disposed on or within the conductive base, wherein the polyoxometalate anions comprise anions having the formula [X_xM_yQ_wO_z]^q−

or the formula [X_xM_yQ_wO_zR_r]^q−

wherein M and Q are independently selected from Ta, V, Mo, Co, Cr, Ni, Nb, W, Ti, Fe, Ir, Ru, Zr, Mn, Zn, Pd, Sn, Pt, or Cu;

X is selected from P, Si, B, Ge, As, or Sb;

R is a covalently bonded substituent;

x, y, w, z, and r are integers, wherein y and z are at least 5 and x, w, and r are at least 0; and

q is an integer that represents the charge of the anion; and

at least one conductor attached to the at least one electrode for conducting electrical energy to the at least one electrode from the electronic subassembly for stimulation of adjacent tissue when implanted.

2. The implantable microstimulator device of claim 1, further comprising a coating disposed on the conductive base, wherein at least a portion of the polyoxometalate anions are dispersed in the coating.

3. The implantable microstimulator device of claim 2, wherein the coating comprises a conductive polymer carrier within which the portion of the polyoxometalate anions are dispersed.

4. The implantable microstimulator device of claim 1, wherein at least a portion of the polyoxometalate anions are dispersed within the conductive base.

5. The implantable microstimulator device of claim 1, wherein at least a portion of the polyoxometalate anions are attached to a surface of the conductive base.

6. The implantable microstimulator device of claim 1, wherein the polyoxometalate anions comprise anions having the formula [X_xM_yQ_wO_z]^q−

.

8. The implantable microstimulator device of claim 1, wherein the implantable microstimulator device has a length in a range of 10 to 30 mm.

14. The implantable microstimulator device of claim 1, wherein the polyoxometalate anions comprise anions having the formula [X_xM_yQ_wO_z]^q−

.

20. The implantable microstimulator device of claim 1, wherein the polyoxometalate anions comprise anions having the formula [X_xM_yQ_wO_z]^q−

.

7. A stimulation system, comprising:

a control module comprising a housing;

a power source disposed in the housing; and

an electronic subassembly coupled to the power source; and

a lead coupleable to the control module and comprising a plurality of electrodes forming a plurality of columns of longitudinally spaced-apart electrodes at a distal end of the lead, each electrode comprising a conductive base and polyoxometalate anions disposed on or within the conductive base, wherein the polyoxometalate anions comprise anions having the formula [X_xM_yQ_wO_z]^q−

or the formula [X_xM_yQ_wO_zR_r]^q−

wherein M and Q are independently selected from Ta, V, Mo, Co, Cr, Ni, Nb, W, Ti, Fe, Ir, Ru, Zr, Mn, Zn, Pd, Sn, Pt, or Cu;

X is selected from P, Si, B, Ge, As, or Sb;

R is a covalently bonded substituent;

x, y, w, z, and r are integers, wherein y and z are at least 5 and x, w, and r are at least 0; and

q is an integer that represents the charge of the anion; and

at least one conductor attached to the plurality of electrodes and coupleable to the electronic subassembly of the control module to provide electrical energy to the plurality of electrodes for stimulation of adjacent tissue when implanted.

9. The stimulation system of claim 7, wherein the plurality of electrodes are disposed on a paddle.

10. The stimulation system of claim 7, further comprising a coating disposed on the conductive base, wherein at least a portion of the polyoxometalate anions are dispersed in the coating.

11. The stimulation system of claim 10, wherein the coating comprises a conductive polymer carrier within which the portion of the polyoxometalate anions are dispersed.

12. The stimulation system of claim 7, wherein at least a portion of the polyoxometalate anions are dispersed within the conductive base.

13. The stimulation system of claim 7, wherein at least a portion of the polyoxometalate anions are attached to a surface of the conductive base.

15. A stimulation system, comprising:

a control module comprising a housing;

a power source disposed in the housing; and

an electronic subassembly coupled to the power source; and

a lead coupleable to the control module and comprising a plurality of ring electrodes longitudinally spaced-apart at a distal end of the lead, each electrode comprising a conductive base and polyoxometalate anions disposed on or within the conductive base, wherein the polyoxometalate anions comprise anions having the formula [X_xM_yQ_wO_z]^q−

or the formula [X_xM_yQ_wO_zR_r]q⁻

wherein M and Q are independently selected from Ta, V, Mo, Co, Cr, Ni, Nb, W, Ti, Fe, Ir, Ru, Zr, Mn, Zn, Pd, Sn, Pt, or Cu;

X is selected from P, Si, B, Ge, As, or Sb;

R is a covalently bonded substituent;

x, y, w, z, and r are integers, wherein y and z are at least 5 and x, w, and r are at least 0; and

q is an integer that represents the charge of the anion; and

at least one conductor attached to the plurality of electrodes and coupleable to the electronic subassembly of the control module to provide electrical energy to the plurality of electrodes for stimulation of adjacent tissue when implanted.

16. The stimulation system of claim 15, further comprising a coating disposed on the conductive base, wherein at least a portion of the polyoxometalate anions are dispersed in the coating.

17. The stimulation system of claim 16, wherein the coating comprises a conductive polymer carrier within which the portion of the polyoxometalate anions are dispersed.

18. The stimulation system of claim 15, wherein at least a portion of the polyoxometalate anions are dispersed within the conductive base.

19. The stimulation system of claim 15, wherein at least a portion of the polyoxometalate anions are attached to a surface of the conductive base.